Zolpidem
Form: Sublingual tablets, Oral Spray(US only)
Strength: Sublingual tablets: 1.75 mg, 3.5 mg, 5 mg, 10 mg; Oral spray (US): 5 mg/spray
Reference Brands: Zolpidem and Generics
Category: Antipsychotropic Drugs
Zolpidem is a non-benzodiazepine sedative-hypnotic used for the short-term treatment of insomnia. It is available in multiple forms including immediate-release tablets (5 mg, 10 mg), extended-release tablets (6.25 mg, 12.5 mg), sublingual tablets, and oral spray. Leading brands include Ambien®, Ambien CR®, Stilnoct®, Edluar®, and Intermezzo®. Widely prescribed in the US and EU, Zolpidem enhances GABA activity to promote sleep onset and maintenance. Pharma B2B platforms offer bulk procurement of Zolpidem from GMP and US FDA/EU-compliant manufacturers, ensuring quality, regulatory adherence, and global distribution capabilities for hospitals, wholesalers, and sleep disorder treatment providers.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Related Products
Risperidone Long-Acting Injection
Strength: 12.5 mg, 25 mg, 37.5 mg, 50 mg vials/syringes
Form: Long-Acting Injection
Reference Brands: Risperdal Consta(US &EU)
View Details
Zuclopenthixol Ong-Acting Im Injection (Depot)
Strength: 200 mg/mL, 500 mg/mL
Form: Long-acting IM Injection (Depot)
Reference Brands: Clopixol Depot®(US)
View Details
Zuclopenthixol Short-Acting Intramuscular Injection
Strength: 50 mg/mL
Form: Short-acting Intramuscular Injection
Reference Brands: Clopixol-Acuphase®
View Details
Zuclopenthixol Tablets
Strength: 10 mg, 25 mg, 40 mg
Form: Oral Tablets
Reference Brands: Clopixol®(EU)
View Details